Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,921 | 9,814 | 8,023 | 6,724 | 8,572 |
| Receivables | 2,000 | N/A | N/A | N/A | N/A |
| TOTAL | $27,738 | $10,815 | $9,910 | $8,840 | $11,968 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 283 | 321 | 360 | 400 | 443 |
| TOTAL | $283 | $321 | $360 | $400 | $443 |
| Total Assets | $28,021 | $11,136 | $10,270 | $9,240 | $12,411 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,159 | 29,561 | 62,078 | 62,328 | 62,773 |
| Accrued Expenses | 26,478 | 24,828 | 31,057 | 28,135 | 26,230 |
| Other current liabilities | N/A | N/A | 6,172 | 33 | 6,950 |
| TOTAL | $69,555 | $84,182 | $129,476 | $123,410 | $129,053 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43,676 | 43,712 | 176 | 211 | 247 |
| TOTAL | $43,676 | $43,712 | $176 | $211 | $247 |
| Total Liabilities | $113,231 | $127,894 | $129,652 | $123,621 | $129,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,219,842 | 1,214,900 | 993,366 | 979,527 | 931,152 |
| Common Shares | 1,220 | 1,059 | 990 | 971 | 931 |
| Retained earnings | -872,304 | -891,531 | -874,744 | -862,824 | -853,261 |
| TOTAL | $-85,210 | $-116,758 | $-119,382 | $-114,381 | $-116,889 |
| Total Liabilities And Equity | $28,021 | $11,136 | $10,270 | $9,240 | $12,411 |